Clinical Trials on Acquired Pure Red Cell Aplasia
Total 3941 results
-
Emory UniversityNational Cancer Institute (NCI); Takeda; National Institutes of Health (NIH); Janssen...Active, not recruiting
-
SanofiCompletedPlasma Cell MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; SmithKline BeechamCompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
Mayo ClinicArizona State UniversityCompletedMultiple Myeloma | Plasma Cell DisorderUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
University of WashingtonBristol-Myers SquibbActive, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma and other conditionsUnited States
-
SanofiRecruitingPlasma Cell MyelomaCzechia, Australia, Chile, France, Spain, United States, Brazil, China, Greece, Japan, Korea, Republic of, Sweden, Taiwan, Finland, Italy, Russian Federation
-
Mayo ClinicRecruitingPlasma Cell MyelomaUnited States
-
SanofiRecruitingPlasma Cell MyelomaGermany, United States, Argentina, Austria, Belgium, China, France, Hong Kong, Italy, Japan, Puerto Rico, Russian Federation, Spain, Switzerland, United Arab Emirates, United Kingdom, Kuwait, Saudi Arabia, Netherlands, Taiwan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States
-
SanofiCompleted
-
SanofiCompletedPlasma Cell MyelomaUnited States, Czechia, France
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
University of California, San FranciscoCompletedFollicular Lymphoma | Renal Cell Carcinoma | Acute Myeloid Leukemia | Multiple Myeloma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Aplastic Anemia | Myelodysplasia | NHL | Myeloproliferative DiseasesUnited States
-
Robert Flavell, MD, PhDNational Cancer Institute (NCI)RecruitingMultiple Myeloma | Plasma Cell MyelomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Recruiting
-
Emory UniversityNational Cancer Institute (NCI); GlaxoSmithKlineRecruitingPlasma Cell MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingPlasma Cell MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
SanofiActive, not recruitingPlasma Cell MyelomaMexico, Sweden, Poland, France, Czechia, Greece, Taiwan, Lithuania, Portugal, Spain, Australia, Italy, New Zealand, Russian Federation, Turkey, Japan, United States, Belgium, China, Denmark, Germany
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); AmgenActive, not recruitingPlasma Cell MyelomaUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom
-
Thomas Jefferson UniversityJanssen Scientific Affairs, LLCActive, not recruitingPlasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)WithdrawnPlasma Cell MyelomaUnited States
-
SanofiCompletedPlasma Cell MyelomaFrance, Spain, Greece, Korea, Republic of, United States, Australia, Belgium, Canada, Czechia, Denmark, Germany, Hungary, Italy, Japan, New Zealand, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden, Taiwan, Turkey, United...
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States
-
SanofiCompletedPlasma Cell MyelomaFrance, Italy, Czechia, Greece, Spain, Canada, Australia, United States, Brazil, Hungary
-
Roswell Park Cancer InstituteCompletedPlasma Cell MyelomaUnited States
-
Ohio State University Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)WithdrawnMultiple Myeloma | Plasma Cell MyelomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative DisorderUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
European Organisation for Research and Treatment...UnknownLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmFrance, Belgium, Netherlands, Germany, Italy
-
AmgenCompletedType II Refractory Celiac Disease (RCD-II) | In-situ Small Bowel T-cell LymphomaSpain, United States, Finland, France, Netherlands
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMyeloma-Multiple | Myeloma, Plasma-CellUnited States
-
University of California, San FranciscoWithdrawnLymphoma | Leukemia | Plasma Cell Dyscrasia
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.Completed
-
National Cancer Institute (NCI)CompletedMyeloma-Multiple | Myeloma, Plasma-CellUnited States
-
California Cancer ConsortiumNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Boston VA Research Institute, Inc.Dana-Farber Cancer InstituteCompletedPlasma Cell DisorderUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative DisorderUnited States
-
National Cancer Institute (NCI)CompletedMyeloma-Multiple | Myeloma, Plasma-CellUnited States